Carlotta Cerva

672 total citations
24 papers, 249 citations indexed

About

Carlotta Cerva is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Carlotta Cerva has authored 24 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in Carlotta Cerva's work include Tuberculosis Research and Epidemiology (9 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Carlotta Cerva is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Carlotta Cerva collaborates with scholars based in Italy, United States and Cameroon. Carlotta Cerva's co-authors include Massimo Andreoni, Delia Goletti, Gina Gualano, Fabrizio Palmieri, Loredana Sarmati, Francesco Di Gennaro, Silvia Mosti, Raffaella Libertone, Vincenzo Malagnino and Virginia Di Bari and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Microbiology and Infection.

In The Last Decade

Carlotta Cerva

19 papers receiving 244 citations

Peers

Carlotta Cerva

EPIDE

HEPAT

SURGE

RNMI

Maria Aurora Carleo Italy

Yong Xiao China

Pierluigi Blanc Italy

Martin Dupuy France

Germano de Sousa Portugal

Shengxia Yin China

Kamonwan Soonklang Thailand

Cristina Díez Spain

R. Whitney Edwards United States

Jennifer Hoffmann United States

Maria Aurora Carleo Italy

Carlotta Cerva

90 ×0.6

78 ×0.7

EPIDE

65 ×1.3

HEPAT

20 ×0.6

SURGE

4 ×0.2

RNMI

Citations per year, relative to Carlotta Cerva Carlotta Cerva (= 1×) peers Maria Aurora Carleo

Countries citing papers authored by Carlotta Cerva

Since Specialization

Citations

This map shows the geographic impact of Carlotta Cerva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlotta Cerva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlotta Cerva more than expected).

Fields of papers citing papers by Carlotta Cerva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlotta Cerva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlotta Cerva. The network helps show where Carlotta Cerva may publish in the future.

Co-authorship network of co-authors of Carlotta Cerva

This figure shows the co-authorship network connecting the top 25 collaborators of Carlotta Cerva. A scholar is included among the top collaborators of Carlotta Cerva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlotta Cerva. Carlotta Cerva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gualano, Gina, Pietro Vittozzi, Virginia Di Bari, et al.. (2025). A Case of Pulmonary Fibrosis and COVID-19-Related Pneumonia in a Pembrolizumab-Treated Patient. Infectious Disease Reports. 17(3). 53–53.

Mencarini, Paola, S. Carli, Carlotta Cerva, et al.. (2025). Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series. Infectious Disease Reports. 17(2). 28–28.

Bari, Virginia Di, Carlotta Cerva, Raffaella Libertone, et al.. (2025). Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital. Infectious Disease Reports. 17(1). 11–11. 3 indexed citations

Gualano, Gina, Paola Mencarini, Carlotta Cerva, et al.. (2025). Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis. BMC Infectious Diseases. 25(1). 680–680.

Mencarini, Paola, Silvia Mosti, Carlotta Cerva, et al.. (2024). Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital. Antibiotics. 14(1). 7–7.

Mencarini, Paola, S. Carli, Carlotta Cerva, et al.. (2024). Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease. Pathogens. 13(12). 1064–1064. 1 indexed citations

Gualano, Gina, Drieda Zaçe, Silvia Mosti, et al.. (2023). Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective Study. Infectious Disease Reports. 15(6). 735–746.

Fard, Saeid Najafi, Alessandra Aiello, Assunta Navarra, et al.. (2023). Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection. International Journal of Infectious Diseases. 130. S34–S42. 18 indexed citations

Bari, Virginia Di, Gina Gualano, Maria Musso, et al.. (2022). Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics. 11(3). 398–398. 3 indexed citations

10.

Minutolo, Antonella, Marina Potestà, Marco Cirilli, et al.. (2021). Plant microRNAs from Moringa oleifera Regulate Immune Response and HIV Infection. Frontiers in Pharmacology. 11. 620038–620038. 24 indexed citations

11.

Musso, Maria, Francesco Di Gennaro, Gina Gualano, et al.. (2021). Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy. Infection. 49(5). 1061–1064. 22 indexed citations

12.

Malagnino, Vincenzo, Carlotta Cerva, Elisabetta Teti, et al.. (2021). Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers. Scientific Reports. 11(1). 3965–3965. 6 indexed citations

13.

Macchi, Beatrice, Francesca Marino‐Merlo, Antonella Minutolo, et al.. (2020). Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients. Pathogens. 9(12). 1047–1047. 2 indexed citations

14.

Svicher, Valentina, Romina Salpini, Vincenzo Malagnino, et al.. (2019). New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts. Viruses. 11(9). 783–783. 12 indexed citations

15.

Campogiani, Laura, Carlotta Cerva, Gaetano Maffongelli, et al.. (2019). Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir. AIDS Research and Therapy. 16(1). 15–15. 8 indexed citations

16.

Malagnino, Vincenzo, Carlotta Cerva, Gaetano Maffongelli, et al.. (2019). HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy. Scientific Reports. 9(1). 11942–11942. 12 indexed citations

17.

Salpini, Romina, Carlotta Cerva, Lorenzo Piermatteo, et al.. (2019). A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases. Digestive and Liver Disease. 51. e67–e67. 1 indexed citations

18.

Ricciardi, Alessandra, Elisa Gentilotti, Luigi Coppola, et al.. (2017). Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. PLoS ONE. 12(5). e0176881–e0176881. 16 indexed citations

19.

Cerva, Carlotta, Gaetano Maffongelli, Valentina Svicher, et al.. (2017). Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal. BMC Infectious Diseases. 17(1). 566–566. 10 indexed citations

20.

Cerva, Carlotta, Luna Colagrossi, Gaetano Maffongelli, et al.. (2016). Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. Clinical Microbiology and Infection. 22(11). 946.e1–946.e8. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact